肝硬化患者肾功能评估:肌肉量与性别的影响
本研究纳入779例连续肝硬化患者,以51Cr-EDTA测定的肾小球滤过率(mGFR)为参照,比较肌酐与胱抑素C估算的eGFR。结果显示47%患者MDRD-eGFR高估肾功能,女性、Child B和C级及男性骨骼肌量减少是高估的独立危险因素;胱抑素C-eGFR与mGFR相关性更好,对总生存和急性肾损伤的预测优于MDRD-eGFR。
要点
- 肝硬化患者中47%存在MDRD-eGFR高估肾功能。
- 女性、Child B/C级及男性骨骼肌量减少是高估的独立危险因素。
- 胱抑素C-eGFR与mGFR相关性及预后预测均优于MDRD-eGFR。
核心结论
- 肌酐类eGFR高估肾功能的危险因素包括女性、肝功能受损及男性骨骼肌量减少,尤其男性肌少症患者eGFR应谨慎解读。
- 肌酐类eGFR较胱抑素C类eGFR更常被高估,且eGFR高估与不良预后表现密切相关。
研究设计与样本
- 本研究纳入779例连续肝硬化患者,均接受51Cr-乙二胺四乙酸(EDTA)测定mGFR及腹部计算机断层扫描(CT)。
- eGFR分别用肌酐或胱抑素C计算;肌肉量以CT在L3水平的总骨骼肌评估。
主要发现
- MDRD-eGFR在47%的患者中被高估。
- 多因素分析显示女性(校正比值比[aOR] 4.91)、Child B和C级对比A级(aOR 1.69和1.84)及骨骼肌量(aOR 0.89)是与高估相关的独立危险因素。
- 骨骼肌量对高估的影响因性别而异:骨骼肌量减少显著增加男性患者MDRD-eGFR高估风险,但女性患者无此影响。
- 胱抑素C-eGFR与mGFR的相关性优于MDRD-eGFR,且对总生存和急性肾损伤发生率的预测也优于MDRD-eGFR。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Accurate evaluation of renal function in patients with liver cirrhosis is critical for clinical management. However, there are still discrepancies between the measured glomerular filtration rate (mGFR) and creatinine-based estimated GFR (eGFR). In this study, we compared the performance of 2 common eGFR measurements with mGFR and evaluated the impact of low muscle mass on overestimation of renal function in patients with cirrhosis. METHODS: This study included 779 consecutive cirrhotic patients who underwent 51Cr-ethylenediamine tetra acetic acid (EDTA) (as a mGFR) and abdominal computed tomography (CT). The eGFR was calculated using creatinine or cystatin C. Muscle mass was assessed in terms of the total skeletal muscle at L3 level using CT. RESULTS: Modification of diet in renal disease (MDRD)-eGFR was overestimated in 47% of patients. A multivariate analysis showed that female sex (adjusted odds ratio [aOR] 4.91), Child B and C vs. A (aOR 1.69 and 1.84) and skeletal muscle mass (aOR 0.89) were independent risk factors associated with overestimation. Interestingly, the effect of skeletal muscle mass on overestimation varied based on sex. Decreased muscle mass significantly enhanced the risk of overestimation of MDRD-eGFR in male patients, but not in female patients. Cystatin C-based eGFR showed a better correlation with mGFR than MDRD-eGFR; it was also better at predicting overall survival and the incidence of acute kidney injury than MDRD-eGFR. CONCLUSIONS: The risk factors associated with overestimation included female sex, impaired liver function, and decreased muscle mass in males. In particular, eGFR in male patients with sarcopenia should be carefully interpreted. Creatinine-based eGFR was overestimated more often than cystatin C-based eGFR, with overestimation of eGFR closely related to poor prognostic performance. LAY SUMMARY: Overestimation of renal function frequently occurs in patients with liver cirrhosis when using serum creatinine. Decreased muscle mass has a great impact on overestimation of kidney function especially in male patients with cirrhosis. Compared with creatinine, cystatin C was more closely correlated with measured glomerular filtration rate and had a higher predictive ability for renal complications and survival than creatinine.
引用
- Yoo JJ, Kim SG, Kim YS, et al. Estimation of renal function in patients with liver cirrhosis: Impact of muscle mass and sex. J Hepatol. 2019. PMID: 30630010. doi:10.1016/j.jhep.2018.12.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。